Figure 2 — Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets

Research Paper|Volume 15, Issue 6|pp. 2066–2081

Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets

Back to articleFigure 2(2 of 9)

100%

Figure 2.The Kaplan-Meier survival curve was applied to investigate the prognosis of SHCBP1 expression in pan-cancer. (A) Overall survival (B) Disease-free survival.